Sorrento Therapeutics Inc. and Mount Sinai Health System have agreed to join forces in the investigation and development of an antibody cocktail (COVI-Shield) to potentially treat COVID-19.   Carlos Cordon-Cardo, MD, PhD, Irene Heinz Given and John LaPorte Given professor and chair of Pathology, Molecular and Cell-Based Medicine at the Icahn School of Medicine at Mount Sinai and his team screened approximately 15,000 individuals who may have had and recovered from COVID-19 for the presence of an...